In the past 12 months, we’ve signed 25 new distribution agreements with strong, strategic partners located outside of the U.S. who understand our mission and are ready to amplify it.
The result? Our footprint now spans more than 50 countries across Europe, Asia, the Middle East, Africa, and South America.
This is more than growth. It’s momentum with purpose.
We’re unlocking new markets. We’re accelerating access to technologies that improve lives. And we’re doing it with a distribution network that’s not only expanding but solidifying our position as a global leader in medical technology.
Every agreement we sign reflects our commitment to quality, reliability, and long-term value creation. With each new partner, we add strength to the foundation that will support our next phase of innovation.
And we’re not done.
Our expansion continues, because demand is growing, opportunities are multiplying, and our team is ready. With investor support, we can scale faster, reach further, and deliver more solutions to the people who need them most.